[ Price : $8.95]
A Matrix Global Advisors report says more attention should be paid to the ways in which FDA helps and hurts drug price competition...[ Price : $8.95]
The National Institutes of Health proposes new rules on registration and summary results information from some clinical trials for...[ Price : $8.95]
FDA denies a petition to permit a drug company to submit an ANDA demonstrating bioequivalence to BioMarins Kuvan sold in Israel ra...[ Price : $8.95]
Mallinckrodt asks a Maryland federal court to stop FDA from reclassifying its generic form of Concerta from AB to BX.[ Price : $8.95]
The Drug and Device Law Blog says a New Jersey court decision allowing a Reglan failure-to-warn claim to go forward will likely no...[ Price : $8.95]
The U.S. Justice Department files an indictment charging Vascular Solutions and its chief executive officer, Howard Root, with sel...[ Price : $8.95]
FDA issues a partial clinical hold on CytRx Corp. and its clinical trials for cancer therapy aldoxorubicin have been placed on par...[ Price : $8.95]
Novartis says it plans to complete its FDA filing for a new drug to treat heart failure with reduced ejection fraction by the end ...